MSF Supports Patent Challenge To Prevent Johnson & Johnson Extending Protections On TB Drug
Médecins Sans Frontières: TB activists challenge patent in India, in bid to prevent J&J from extending monopoly
“Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. … MSF is urging J&J to refrain from attempts to extend its monopoly that will further delay the availability of quality-assured generic versions of bedaquiline in India, South Africa, and other countries” (2/8).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.